International Journal of Polymer Science

International Journal of Polymer Science / 2011 / Article
Special Issue

Polymeric Biomaterials for Tissue Engineering Applications 2011

View this Special Issue

Research Article | Open Access

Volume 2011 |Article ID 651549 |

Rodman T. H. Chan, Christopher J. Garvey, Helder Marçal, Robert A. Russell, Peter J. Holden, L. John R. Foster, "Manipulation of Polyhydroxybutyrate Properties through Blending with Ethyl-Cellulose for a Composite Biomaterial", International Journal of Polymer Science, vol. 2011, Article ID 651549, 8 pages, 2011.

Manipulation of Polyhydroxybutyrate Properties through Blending with Ethyl-Cellulose for a Composite Biomaterial

Academic Editor: Shanfeng Wang
Received06 May 2011
Accepted30 May 2011
Published28 Jul 2011


Polyhydroxybutyrate (PHB) is widely used as a biomaterial in medical and tissue-engineering applications, a relatively high crystallinity limits its application. Blending PHB with ethyl-cellulose (EtC) was readily achieved to reduce PHB crystallinity and promote its degradation under physiological conditions without undue influence on biocompatibility. Material strength of composite films remained unchanged at 6.5 0.6 MPa with 40% (w/w) EtC loadings. Phase separation between the two biopolymers was determined with PHB crystallinity decreasing from 63% to 47% for films with the same loading. This reduction in crystallinity supported an increase in the degradation rates of composite films from 0.39 to 0.81% wk−1 for PHB and its composite, respectively. No significant change in morphology and proliferation of olfactory ensheathing cells were observed with the composites despite significant increases in average surface roughness (Ra) of the films from 2.90 to 3.65 m for PHB and blends with 80% (w/w) EtC, respectively.

1. Introduction

Polyhydroxyalkanoates (PHAs) are a family of biopolyesters synthesised by a range of microbial species under conditions of environmental stress with excess of carbon [1]. Currently, PHAs consisting of one or more of over 150 different monomer unit have been identified and include the commercially produced polyhydroxybutyrate (PHB) [2, 3]. PHB is the most commonly studied member of the PHA family is biodegradable and biocompatible and used as both a bioplastic and biomaterial for medical devices (Figure 1) [4].

Microbial PHB is comprised of β-hydroxybutyric acid (HBA) monomer units, which is also one of the ketone bodies produced by mammalian cells under conditions of starvation and diabetes and is thought to facilitate biocompatibility in its microbial counterpart which, in the absence of endotoxins, does not trigger any cytotoxic response in mammals [5]. Foster and Tighe have shown that microbial HBA is chemically identical to the mammalian HBA and is recognised by mammalian enzymes [5, 6]. Microbially produced PHB does not trigger an immune and inflammatory response or cause anastomotic failures [7]. As a biomaterial, PHB has been used for various biomedical devices such as sutures, prosthetic devices, and drug delivery systems and for surgical applications [8]. However, the crystalline nature of PHB, its brittleness and low flexibility, long degradation rate under physiological conditions, and poor processability limit its potential for tissue engineering [9]. Modification of PHB physiochemical and material properties through copolymerising and blending have demonstrated successful manipulation of these properties particularly as a bioplastic for environmental applications but with limited success in biomedical scenarios [10, 11].

Similar to PHB, ethyl-cellulose (EtC) is also an FDA- (Food and Drug Administration, USA) approved biomaterial and is widely used as a blood coagulant, coatings for pharmaceutical tablets, and matrices for poorly soluble drugs [12]. Ethyl-cellulose has also been used as a framework in drug-delivery systems for stabilising drug release through the cellulose hydrophilic surface interface [13]. Furthermore, studies have shown that EtC is susceptible to enzyme digestion in human body [14]. In contrast, degradation of PHB proceeds through abiotic hydrolysis and under physiological conditions is a slow process taking years to completely degrade [15]. The rate of PHB degradation has been enhanced by blending PHB with other polymers such as cellulose triacetate (CTAc) and PEG [16, 17].

While there are a variety of reports on PHB-based blends, studies using cellulose derivatives are limited. In the study here, we report on the manipulation of PHB physiochemical and material properties through the addition of ethyl-cellulose as a blending agent with the production of composite PHB-Etc biomaterial films (Figure 1).

2. Experimental

2.1. Reagents

Polyhydroxybutyrate (PHB) of natural origin, ethyl cellulose (48% ethoxyl) and Trypsin were purchased from Sigma Aldrich (Sydney, Australia; Figure 1). Analytical grade chloroform and dimethyl sulfoxide (DMSO) were purchased from Univar, (Seven Hills, Australia). Mammalian cell growth medium, fetal bovine serum (FBS) and Penicillin/Streptococcus antibiotic were obtained from Gibco-Invitrogen (Sydney, Australia). OECs were routinely cultured in Dulbecco’s Modified Eagle’s Medium (DMEM/F12) supplemented with 10% FBS purchased from Lonza (USA).

2.2. Film Fabrication

Biopolymer films were produced by solvent casting as per Zhang et al. [18]. PHB and EtC samples with weight ratios of 100 : 0, 80 : 20, 60 : 40, 40 : 60, and 20 : 80 (w/w) were dissolved in heated chloroform in a sterile sealed vessel (5% w/v, 160 rpm, 50°C). The solution was allowed to cool (22°C, 160 rpm, 15 mins) before pouring into sterile, glass Petri dishes and the solvent evaporated by standing (12 hours, 22°C). The resulting films were subsequently maintained at 40°C under vacuum for 48 hours to remove any solvent residues before annealing at 70°C for 10 days.

2.3. Material characterisation

Material properties of PHB and PHB-EtC films were analysed using a tensile testing instrument (Instron-5543, USA) at 22°C with 30% relative humidity. Films samples (30 mm × 15 mm) were clamped to the calibrated tensiometer using pneumatic grips which slowly moved apart (20 mm min−1). The maximum load, tensile strength and extension at break were calculated using Bluehill computer software (USA). Means from at least 10 samples were determined (n = 10).

Thermal properties of the PHB-EtC films were examined using a DSC-1 Stare system (Mettler Toledo, USA). Samples (5 mg) were sealed in pans and heated at 10°C min−1 from 25°C to 200°C to obtain the melting temperature () and enthalpy of fusion (). Samples were then cooled at the same rate from 200°C to −50°C and reheated from −50°C to 25°C to obtain glass transition temperatures (). The blend (Blend-Xc) and PHB (PHB-Xc) phase crystallinity were calculated using (1), respectively [19] where is the enthalpy of fusion for PHB (146 Jg−1) [19] and is the percentage of PHB in the blended film. Means of at least 15 samples were determined (n = 15).

X-ray diffraction patterns of the PHB-EtC composites were acquired using a Philips X’pert Material Research Diffraction (MRD) System (Holland). Film samples ( mm) were secured on glass slides and aligned with 2θ, z-axis and omega scans (scattering angle range of = 10–30° and scan step size of 0.02° continuous). Radiation of wavelength 1.5406 Å (Cu K-Alpha) were generated using a power of 45 kV and tube current of 40 mA.

Fourier transform infra-red (FTIR) were made on the PHB-EtC films using a Nicolet iS10 FTIR spectrometer (Thermo scientific, USA). FTIR spectra were acquired between 900 and 1800 cm−1 wave numbers by accumulating 64 scans at a resolution of 0.5 cm−1. Optics were purged with nitrogen to suppress signals from carbon dioxide and water vapour.

2.4. Degradation Studies

Preweighed samples of PHB-EtC films (25 × 10 mm) were sterilised through gamma-irradiation and placed into 2 ml Eppendorf tubes. Samples were incubated (37°C, 150 rpm) following the addition of phosphate buffered saline (0.1 M, pH 7.4) with penicillin (100 units mL−1), streptomycin (100 μg mL−1) and fungizone-amphotericin B (2.5 μg mL−1). At periodic intervals samples were removed, filtered, and dried in a dessicator (40°C, 24 h) before allowing to acclimatise at 22°C (atmospherically equilibrated weight). Means of four samples per time point, per sample, were determined. The degradation experiment, modified from Foster et al., was carried out over 105 days [6]. Weight loss (%) was calculated as: where W is the percentage weight loss and and are the initial weight and weight after incubation, respectively; means of 5 samples were determined (n = 5).

2.5. Cell Studies

Murine olfactory ensheathing cells (OECs) were cultivated in medium containing (DMEM, 10% FBS, 250 unit penicillin, 250 μg mL−1 streptomycin and 1 μg mL−1 fungizone-amphotericin B) in T-75 tissue culture flasks incubated at 37°C with 5% CO2[20]. OECs were removed from the flask using trypsin (2.5%) at 70% confluence and cell populations of approximately 2 × 105 cells mL−1 used to inoculate films samples (13 × 13 mm). At periodic intervals, samples were sacrificed, and the films were rinsed twice with 10 mL of PBS, 2 mL of trypsin (2.5%) was subsequently added before incubation (37°C, 2 mins). Cell proliferation was observed over 3 days and cell viability was calculated using a haemocytometer and the trypan blue exclusion technique [20]. Samples were conducted in triplicate (n = 3).

2.6. Microscopy

Cell attachment to PHB-based films were visualised using microscopy. Films were rinsed twice with phosphate buffer saline (PBS, 1%) and fixed in 2.5% glutaraldehyde in 0.1 M PBS buffer (pH 7.2, 4°C, 12 hours). Films were then washed with PBS buffer three times for 5 minutes duration and postfixed in 1% osmium tetroxides (OsO4, 1 hour). After a buffer wash, samples were sequentially dehydrated in ethanol (30%, 50%, 70%, 80%, 90%, 95%, and 100%, 10 minutes each) and critical point dried, adapted from Chung et al. [21]. Specimens were mounted on aluminium stubs and surfaces were coated with a layer of gold particles using a sputter coater (Emitech K550x, England). Samples were subsequently examined using scanning electron microscopy (Hitachi S3400-I, Japan) at 15 kV and 750 mA.

The microtopographies of the PHB-EtC films were mapped using the reflection mode of a confocal scanning laser microscope (CSLM, Leica model TCS-SP, Germany) at excitation and emission wavelengths of 458 and 440–470 nm, respectively. Multiple images through the z-plane were recorded (step size = 2.5 μm). A total of 30 images were used to generate a 3D depth map and calculate average surface roughness values () according to ISO 4298 (2000) using ImageJ software (National Institute of Health, USA): where the average surface roughness () was calculated from the sampling length (L), the plane (z) and the variations of irregularities (dx) from the mean line [3].

2.7. Statistical Analysis

The data are displayed as a mean value with standard deviation of each group. A Student’s t-test was performed to test significance with 95% confidence.

3. Results and Discussion

3.1. PHB-Etc Film Characterisation

FTIR is sensitive to local molecular environments and as a consequence has been widely applied to investigate interactions between macromolecules during crystallisation [22]. In the study here, FTIR measurements on the solvent cast PHB films showed a characteristic spectrum with peaks at 1721 and 1229 cm−1 assigned to stretching of the C=O groups and C-O-C bonds, respectively, in the crystalline matrix. While peaks at 1450 and 1380 cm−1 were characteristic of asymmetric and symmetric methyl group deformation, those at 1260, 1229 and 1044 cm−1 were assigned to C-O-C stretching with C-H deformation, C-O-C stretching in the amorphous regions and C-CH3  stretching [23, 24]. Blending PHB with increasing loads of EtC gradually reduced the peak intensities in the spectra belonging to crystalline PHB as the amorphous content of the composites increased. Contrary to Kumagai et al. who reported blends of PHB with cellulose triacetate  [16], we did not resolve spectral shifts in peaks suggesting no specific interactions between the two biopolymer components (i.e., hydrogen bonding). The spectra appeared to be simple linear combinations of semicrystalline PHB and EtC (Figure 2).

Differential scanning calorimetry (DSC) showed no significant change in the melting point (mp, 175 ± 4°C) and glass transition temperature (Tg, 1 ± 1°C) of PHB in the composite (Figure 3). However, PHB fusion enthalpies () decreased from 92 to 10 J g−1 in films with 80% (w/w) EtC loading. X-ray diffraction patterns and maxima, observed at 14, 17, 22 and 26°, of the PHB-Etc composites were consistent with previous studies (Figure 4) [25]. As the EtC loading increased the relative peak intensities were reduced, such that the composite with 80% (w/w) EtC loading showed a much broader spectrum with the peaks at 14 and 17° only just noticeable. No disruption of the PHB crystal structure was observed, further supporting FTIR data suggesting the apparent separation of crystalline PHB from amorphous PHB and EtC regions into semicrystalline matrices with EtC chains trapped in the PHB lamellae [26, 27]. The results reported here are consistent with that of Scandola who investigated phase behaviour in PHB and Etc blends and the influence this blending had on environmental degradation of these composites [27].

Differentiation between the crystalline and amorphous regions revealed that as the EtC content in the blend increased, the percentage crystallinity of the films decreased from 63.5 ± 3.3% [19] in PHB films to 9.2 ± 1.5% when the films possessed only 20% (w/w) PHB. (Figure 5(a)). Similarly, the increasing load of EtC disrupted the crystalline process for the PHB which decreased by approximately 32% to 31.5 ± 4.2% with 80% (w/w) EtC loading consistent with the work of Zhang et al. who reported blends of PHB with starch acetate (Figure 5(a)) [18].

Changes in film crystallinity as a consequence of blending with EtC, anticipates an influence on the material properties of the PHB-EtC composite films. However, Figure 5(b) shows no significant change in tensile strength as the EtC loading increased to 40% (w/w) before a dramatic decrease from approximately 6.83 ± 1.05 to 0.84 ± 0.33 MPa (Figure 5(b)). In contrast, extension to break of the films showed an apparently linear decrease from 1.58 + 0.38% for PHB to 0.52 + 0.12% for composites containing 60% (w/w) EtC (). Garvey et al. have shown that crystallisation increases in annealed PHB-EtC films when compared to similarly annealed PHB films [28]. Furthermore, The use of relatively high temperatures during film fabrication has been shown to support nucleation and spherulite formation in PHB films while reducing the distance between the PHB granules in the matrix [9]. In the study here, PHB-EtC composites with 20% (w/w) EtC loadings annealed at 25°C exhibited optimal mechanical properties, since tensile strength and extension at break point were maintained (Figure 5(b)).

3.2. Film Degradation

In addition to influencing material properties, crystallinity can also dictate abiotic degradation behaviour. Reduction of PHB fractional crystallinity makes films more permeable to water molecules and consequently increase hydrolysis of the ester bonds [29]. When incubated under physiological conditions (pH 7.4, 37°C, 160 rpm) PHB and composites films with loadings up to 40% (w/w) EtC no significant weight loss for the first 40 days, while films with higher EtC loadings exhibited weight loss earlier after only 20 days (Figure 6). Figure 6 clearly shows that increasing the EtC loading in the PHB-EtC films increased their degradation, such that PHB films had lost approximately 3.5% of their initial weight after 105 days incubation while composites with 20% (w/w) PHB lost about 12% of their initial weight. Furthermore, weight loss rates were linear and increased significantly () from 0.39% wk−1 for PHB films to 0.81 and 1.34% wk−1 for PHB blended with 40 and 80% (w/w) EtC, respectively.

3.3. Cellular Responses to PHB-Etc Films

Blends of PHB with EtC are commercially attractive as both biopolymers are FDA approved and have demonstrated success as biomedical devices. Blending with EtC reduces the PHB crystallinity and permits manipulation of film material properties and more favourable degradation under physiological conditions. In the study here, the influence of EtC on biocompatibility on the PHB films was compared using adult olfactory ensheathing cells (OECs). Figure 7 shows that OECs readily attached to PHB and its composite with 20% (w/w) EtC and exhibited healthy morphology with many filament extensions comparable to cells in an asynchronous control with the absence of biomaterials. Furthermore, while cell proliferations appeared to be slightly greater for the PHB homopolymer, these were not significant in the course of this study (Figure 8). In all cases, OEC viability was maintained over 95% for each of the films during duration of the study.

Irregular porous surfaces of PHB-based films have been shown to influence cell adhesion and growth [29]. Microtopographies of the films clearly show changes in surface structures as a consequence of EtC blending (Figure 9). Depth maps derived from these images were used to determine the average surface roughness’s () as per ISO 4298 (Figure 10). PHB films exhibited a 2.91 ± 0.12 μm, as the EtC content increased the also increased. Composite films with 80% (w/w) EtC loadings had the most irregular surface with a significantly greater value of 3.74 ± 0.10 μm (Figure 10, ). In comparison to the study here, Zhao et al. have reported that increasing surface roughness in PHA films reduced murine fibroblast attachment, with cells apparently preferring a smoother surface [30].

4. Conclusions

The highly crystalline nature of PHB limits its applications as a biomaterial for medical devices. Manipulation of composition and processing are used to promote more favourable properties in PHB-based devices [31, 32]. In the research reported here, we have combined PHB with another FDA-approved biomaterial, ethyl cellulose. Blending of these two components produced composite films with significant reductions in crystallinity which promoted their degradation under physiological conditions but did not significantly compromise their material properties or biocompatibility. It is anticipated that with the added control of annealing we can effectively “tailor” PHB-based biomaterials through blending to support biomedical device fabrication such as nerve conduits for neuronal regeneration as well as the development of tissue engineering matrices.


  1. F. M. Kapritchkoff, A. P. Viotti, R. C. P. Alli et al., “Enzymatic recovery and purification of polyhydroxybutyrate produced by Ralstonia eutropha,” Journal of Biotechnology, vol. 122, no. 4, pp. 453–462, 2006. View at: Publisher Site | Google Scholar
  2. T. Freier, “Biopolyesters in tissue engineering applications,” Advances in Polymer Science, vol. 203, no. 1, pp. 1–61, 2006. View at: Publisher Site | Google Scholar
  3. C. A. Woolnough, T. Charlton, L. H. Yee, M. Sarris, and L. J. R. Foster, “Surface changes in polyhydroxyalkanoate films during biodegradation and biofouling,” Polymer International, vol. 57, no. 9, pp. 1042–1051, 2008. View at: Publisher Site | Google Scholar
  4. L. J. Chen and M. Wang, “Production and evaluation of biodegradable composites based on PHB-PHV copolymer,” Biomaterials, vol. 23, no. 13, pp. 2631–2639, 2002. View at: Publisher Site | Google Scholar
  5. L. J. R. Foster and B. J. Tighe, “Enzymatic assay of hydroxybutyric acid monomer formation in poly(β-hydroxybutyrate) degradation studies,” Biomaterials, vol. 16, no. 4, pp. 341–343, 1995. View at: Publisher Site | Google Scholar
  6. L. J. R. Foster and B. J. Tighe, “In vitro hydrolytic degradation of centrifugally spun polyhydroxybutyrate-pectin composite fibres,” Polymer International, vol. 58, no. 12, pp. 1442–1451, 2009. View at: Publisher Site | Google Scholar
  7. S. Philip, T. Keshavarz, and I. Roy, “Polyhydroxyalkanoates: biodegradable polymers with a range of applications,” Journal of Chemical Technology and Biotechnology, vol. 82, no. 3, pp. 233–247, 2007. View at: Publisher Site | Google Scholar
  8. Z. W. Dai, X. H. Zou, and G. Q. Chen, “Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) as an injectable implant system for prevention of post-surgical tissue adhesion,” Biomaterials, vol. 30, no. 17, pp. 3075–3083, 2009. View at: Publisher Site | Google Scholar
  9. J. W. You, H. J. Chiu, and T. M. Don, “Spherulitic morphology and crystallization kinetics of melt-miscible blends of poly(3-hydroxybutyrate) with low molecular weight poly(ethylene oxide),” Polymer, vol. 44, no. 15, pp. 4355–4362, 2003. View at: Publisher Site | Google Scholar
  10. K. Zhao, Y. Deng, J. C. Chen, and G. Q. Chen, “Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility,” Biomaterials, vol. 24, no. 6, pp. 1041–1045, 2003. View at: Publisher Site | Google Scholar
  11. C. Chen, C. H. Yu, Y. C. Cheng, P. H. F. Yu, and M. K. Cheung, “Biodegradable nanoparticles of amphiphilic triblock copolymers based on poly(3-hydroxybutyrate) and poly(ethylene glycol) as drug carriers,” Biomaterials, vol. 27, no. 27, pp. 4804–4814, 2006. View at: Publisher Site | Google Scholar
  12. M. M. Crowley, B. Schroeder, A. Fredersdorf et al., “Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion,” International Journal of Pharmaceutics, vol. 269, no. 2, pp. 509–522, 2004. View at: Publisher Site | Google Scholar
  13. H. Dong, Q. Xu, Y. Li, S. Mo, S. Cai, and L. Liu, “The synthesis of biodegradable graft copolymer cellulose-graft-poly(l-lactide) and the study of its controlled drug release,” Colloids and Surfaces B: Biointerfaces, vol. 66, no. 1, pp. 26–33, 2008. View at: Publisher Site | Google Scholar
  14. J. Chen, S. Jo, and K. Park, “Polysaccharide hydrogels for protein drug delivery,” Carbohydrate Polymers, vol. 28, no. 1, pp. 69–76, 1995. View at: Google Scholar
  15. D. S. Rosa, N. T. Lotto, D. R. Lopes, and C. G. F. Guedes, “The use of roughness for evaluating the biodegradation of poly-β-(hydroxybutyrate) and poly-β-(hydroxybutyrate-co-β-valerate),” Polymer Testing, vol. 23, no. 1, pp. 3–8, 2004. View at: Publisher Site | Google Scholar
  16. Y. Kumagai, Y. Kanesawa, and Y. Doi, “Enzymatic degradation of microbial poly(3-hydroxybutyrate) films,” Makromolekular Chemie, vol. 193, no. 1, pp. 53–57, 1992. View at: Google Scholar
  17. X. J. Loh, K. K. Tan, X. Li, and J. Li, “The in vitro hydrolysis of poly(ester urethane)s consisting of poly[(R)-3-hydroxybutyrate] and poly(ethylene glycol),” Biomaterials, vol. 27, no. 9, pp. 1841–1850, 2006. View at: Publisher Site | Google Scholar
  18. L. Zhang, X. Deng, and Z. Huang, “Miscibility, thermal behaviour and morphological structure of poly(3-hydroxybutyrate) and ethyl cellulose binary blends,” Polymer, vol. 38, no. 21, pp. 5379–5387, 1997. View at: Google Scholar
  19. P. J. Barham, A. Keller, E. L. Otun, and P. A. Holmes, “Crystallization and morphology of a bacterial thermoplastic: poly-3-hydroxybutyrate,” Journal of Materials Science, vol. 19, no. 9, pp. 2781–2794, 1984. View at: Publisher Site | Google Scholar
  20. H. Marçal, N. S. Wanandy, V. Sanguanchaipaiwong et al., “BioPEGylation of polyhydroxyalkanoates: influence on properties and satellite-stem cell cycle,” Biomacromolecules, vol. 9, no. 10, pp. 2719–2726, 2008. View at: Publisher Site | Google Scholar
  21. R. S. Chung, A. Woodhouse, S. Fung et al., “Olfactory ensheathing cells promote neurite sprouting of injured axons in vitro by direct cellular contact and secretion of soluble factors,” Cellular and Molecular Life Sciences, vol. 61, no. 10, pp. 1238–1245, 2004. View at: Publisher Site | Google Scholar
  22. C. Vogel, E. Wessel, and H. W. Siesler, “FT-IR imaging spectroscopy of phase separation in blends of poly(3-hydroxybutyrate) with poly(L-lactic acid) and poly(ε-caprolactone),” Biomacromolecules, vol. 9, no. 2, pp. 523–527, 2008. View at: Publisher Site | Google Scholar
  23. T. Furukawa, H. Sato, R. Murakami et al., “Structure, dispersibility, and crystallinity of poly(hydroxybutyrate)/ poly(L-lactic acid) blends studied by FT-IR microspectroscopy and differential scanning calorimetry,” Macromolecules, vol. 38, no. 15, pp. 6445–6454, 2005. View at: Publisher Site | Google Scholar
  24. L. J. R. Foster, V. Sanguanchaipaiwong, C. L. Gabelish, J. Hook, and M. Stenzel, “A natural-synthetic hybrid copolymer of polyhydroxyoctanoate-diethylene glycol: biosynthesis and properties,” Polymer, vol. 46, no. 17, pp. 6587–6594, 2005. View at: Publisher Site | Google Scholar
  25. B. L. Hurrell and R. E. Cameron, “A wide-angle X-ray scattering study of the ageing of poly(hydroxybutyrate),” Journal of Materials Science, vol. 33, no. 7, pp. 1709–1713, 1998. View at: Google Scholar
  26. T. Wang, G. Cheng, S. Ma, Z. Cai, and L. Zhang, “Crystallization behavior, mechanical properties, and environmental biodegradability of poly(β-hydroxybutyrate)/cellulose acetate butyrate blends,” Journal of Applied Polymer Science, vol. 89, no. 8, pp. 2116–2122, 2003. View at: Publisher Site | Google Scholar
  27. M. Scandola, “Polymer blends based on bacterial poly(3-hydroxybutyrate),” Canadian Journal of Microbiology, vol. 41, supplement 1, pp. 310–315, 1995. View at: Google Scholar
  28. C. J. Garvey, R. A. Russell, V. M. Garamus, F. Boue, L. J. R. Foster, and P. J. Holden, Small Angle Neutron Scattering Study of the Interface between Ethylcellulose and Polyhydroxyalkanoate Blends during Annealing, Abstract, SAS2009, ANSTO, Oxford, UK, 2009.
  29. I. I. Muhamad, L. K. Joon, and M. Noor, “Comparing the degradation of poly-β-(hydroxybutyrate), 39-46 poly-β-(hydroxybutyrate-co-β-valerate)(PHBV) and PHBV/cellulose triacetate blend,” Malaysian Polymer Journal, vol. 1, no. 1, pp. 39–46, 2006. View at: Google Scholar
  30. Z. Kai, D. Ying, and C. Guo-Qiang, “Effects of surface morphology on the biocompatibility of polyhydroxyalkanoates,” Biochemical Engineering Journal, vol. 16, no. 2, pp. 115–123, 2003. View at: Publisher Site | Google Scholar
  31. L. J. R. Foster, “Biosynthesis, properties and potential of natural-synthetic hybrids of polyhydroxyalkanoates and polyethylene glycols,” Applied Microbiology and Biotechnology, vol. 75, no. 6, pp. 1241–1247, 2007. View at: Publisher Site | Google Scholar
  32. B. Hazer, “Amphiphilic poly(3-hydroxyalkanoate)s: potential candidates for medical applications,” Energy and Power Engineering, vol. 2, no. 1, pp. 31–38, 2010. View at: Google Scholar

Copyright © 2011 Rodman T. H. Chan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.